Nuveen’s Verrica Pharmaceuticals VRCA Stock Holding History

Nuveen’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,503	Closed	-$138K	–	3345
2024 Q3	$138K	Hold	9,503	–	–	﹤0.01%	3280
2024 Q2	$693K	Hold	9,503	–	–	﹤0.01%	2882
2024 Q1	$563K	Hold	9,503	–	–	﹤0.01%	2935
2023 Q4	$696K	Hold	9,503	–	–	﹤0.01%	2889
2023 Q3	$369K	Hold	9,503	–	–	﹤0.01%	2929
2023 Q2	$548K	Buy	+9,503	New	+$577K	﹤0.01%	2893
2022 Q2	–	Sell	-3,279	Closed	-$277K	–	3494
2022 Q1	$277K	Hold	3,279	–	–	﹤0.01%	3137
2021 Q4	$297K	Hold	3,279	–	–	﹤0.01%	3181
2021 Q3	$399K	Hold	3,279	–	–	﹤0.01%	3208
2021 Q2	$371K	Hold	3,279	–	–	﹤0.01%	3195
2021 Q1	$497K	Sell	3,279 -1,426	-30%	-$197K	﹤0.01%	3100
2020 Q4	$542K	Buy	4,705 +79	+2%	+$7.26K	﹤0.01%	3025
2020 Q3	$358K	Buy	4,626 +395	+9%	+$32.4K	﹤0.01%	3040
2020 Q2	$466K	Sell	4,231 -806	-16%	-$93.2K	﹤0.01%	2929
2020 Q1	$550K	Buy	5,037 +410	+9%	+$54K	﹤0.01%	2732
2019 Q4	$735K	Buy	4,627 +251	+6%	+$37K	﹤0.01%	2796
2019 Q3	$646K	Buy	4,376 +2,377	+119%	+$265K	﹤0.01%	2866
2019 Q2	$232K	Buy	+1,999	New	+$188K	﹤0.01%	3162

Other funds holding VRCA

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return